These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2175592)

  • 1. Replication of murine cytomegalovirus in mast cells.
    Gibbons AE; Price P; Robertson TA; Papadimitriou JM; Shellam GR
    Arch Virol; 1990; 115(3-4):299-307. PubMed ID: 2175592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of beta-2-microglobulin on the infectivity of murine cytomegalovirus.
    Wykes MN; Price P; Shellam GR
    Arch Virol; 1992; 123(1-2):59-72. PubMed ID: 1312826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the morphogenesis of murine cytomegalovirus.
    Weiland F; Keil GM; Reddehase MJ; Koszinowski UH
    Intervirology; 1986; 26(4):192-201. PubMed ID: 3038772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow-derived cultured mast cells and peritoneal mast cells as targets of a growth activity secreted by BALB/3T3 fibroblasts.
    Jozaki K; Kuriu A; Hirota S; Onoue H; Ebi Y; Adachi S; Ma JY; Tarui S; Kitamura Y
    Exp Hematol; 1991 Mar; 19(3):185-90. PubMed ID: 1847337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the production of murine cytomegalovirus and interferon in macrophages.
    Yamaguchi T; Shinagawa Y; Pollard RB
    J Gen Virol; 1988 Dec; 69 ( Pt 12)():2961-71. PubMed ID: 2462012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of tumour necrosis factor-alpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection.
    Yerkovich ST; Olver SD; Lenzo JC; Peacock CD; Price P
    Immunology; 1997 May; 91(1):45-52. PubMed ID: 9203964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in replication of low-passage MCMV HaNa1 in BALB/c, C57BL/6 and NOD mice and role of different branches of immunity in susceptibility.
    Xiang J; Zhang S; Leclercq G; Nauwynck H
    Virus Res; 2016 Aug; 221():38-46. PubMed ID: 27173788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H-2 class I loci determine sensitivity to MCMV in macrophages and fibroblasts.
    Price P; Gibbons AE; Shellam GR
    Immunogenetics; 1990; 32(1):20-6. PubMed ID: 2165035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominant utilization of V beta 8+ T cell receptor genes in the H-2Ld-restricted cytotoxic T cell response against the immediate-early protein pp89 of the murine cytomegalovirus.
    Rodewald HR; Koszinowski UH; Eichmann K; Melchers I
    J Immunol; 1989 Dec; 143(12):4238-43. PubMed ID: 2556481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine cytomegalovirus infection of reaggregate cultures of fetal mouse brain.
    Bale JF; O'Neil M; Wentzien J; Schelper R
    J Neuropathol Exp Neurol; 1987 Jan; 46(1):72-83. PubMed ID: 3025379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine peritoneal macrophages support murine cytomegalovirus replication.
    Shanley JD; Pesanti EL
    Infect Immun; 1983 Sep; 41(3):1352-9. PubMed ID: 6309668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
    Morello CS; Cranmer LD; Spector DH
    J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication of murine cytomegalovirus in murine Y-1 cells.
    Shanley JD; Lutwick LI; Donta ST
    J Med Virol; 1979; 4(4):261-8. PubMed ID: 232142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inflammatory macrophage response to murine cytomegalovirus in genetically susceptible mice.
    Price P; Winter JG; Shellam GR
    Arch Virol; 1989; 106(1-2):35-50. PubMed ID: 2548459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of Fasciola hepatica tegumental antigens on mast cell function.
    Vukman KV; Adams PN; Dowling D; Metz M; Maurer M; O'Neill SM
    Int J Parasitol; 2013 Jun; 43(7):531-9. PubMed ID: 23535069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I Interferon Released by Myeloid Dendritic Cells Reversibly Impairs Cytomegalovirus Replication by Inhibiting Immediate Early Gene Expression.
    Holzki JK; Dağ F; Dekhtiarenko I; Rand U; Casalegno-Garduño R; Trittel S; May T; Riese P; Čičin-Šain L
    J Virol; 2015 Oct; 89(19):9886-95. PubMed ID: 26202227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of interferon induction in mice of resistant and susceptible strains during murine cytomegalovirus infection.
    Allan JE; Shellam GR
    J Gen Virol; 1985 May; 66 ( Pt 5)():1105-12. PubMed ID: 2582082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of murine cytomegalovirus myocarditis: cellular infiltration of the heart and virus persistence.
    Lenzo JC; Fairweather D; Cull V; Shellam GR; James Lawson CM
    J Mol Cell Cardiol; 2002 Jun; 34(6):629-40. PubMed ID: 12054850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.
    Lawson CM; Grundy JE; Shellam GR
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1987-98. PubMed ID: 2841411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lethal infection with murine cytomegalovirus after early viral replication in the spleen.
    Katzenstein DA; Yu GS; Jordan MC
    J Infect Dis; 1983 Sep; 148(3):406-11. PubMed ID: 6311909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.